OrthAlign Receives 510(k) FDA Clearance for ORTHALIGN PLUS System

OrthAlign, a privately held medical device company, announced it has received 510(k) clearance from the United States Food and Drug Administration to market its ORTHALIGN PLUS system.

Advertisement

The computer-controlled system is a palm-sized, single-use navigation device for total hip arthroplasty (both anterior and posterior approaches) and total knee arthroplasty surgeries.

More Articles on Devices:  

FDA Clears Renovis Surgical’s Tesera Anterior Lumbar Interbody Fusion Cage
Device Companies — 7 Key Notes — Biomet, MAKO Surgical & More
46 Spine & Orthopedic Devices Receive FDA 510(k) Clearance in October

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.